oxidopamine has been researched along with Menopause in 1 studies
Oxidopamine: A neurotransmitter analogue that depletes noradrenergic stores in nerve endings and induces a reduction of dopamine levels in the brain. Its mechanism of action is related to the production of cytolytic free-radicals.
oxidopamine : A benzenetriol that is phenethylamine in which the hydrogens at positions 2, 4, and 5 on the phenyl ring are replaced by hydroxy groups. It occurs naturally in human urine, but is also produced as a metabolite of the drug DOPA (used for the treatment of Parkinson's disease).
Menopause: The last menstrual period. Permanent cessation of menses (MENSTRUATION) is usually defined after 6 to 12 months of AMENORRHEA in a woman over 45 years of age. In the United States, menopause generally occurs in women between 48 and 55 years of age.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rodriguez-Perez, AI | 1 |
| Borrajo, A | 1 |
| Valenzuela, R | 1 |
| Lanciego, JL | 1 |
| Labandeira-Garcia, JL | 1 |
1 other study available for oxidopamine and Menopause
| Article | Year |
|---|---|
Critical period for dopaminergic neuroprotection by hormonal replacement in menopausal rats.
Topics: Angiotensin Receptor Antagonists; Animals; Cells, Cultured; Dopaminergic Neurons; Estrogen Receptor | 2015 |